A Phase II Study of Velcade and Temsirolimus for Relapsed or Refractory B-cell Non-Hodgkin Lymphoma.
Phase of Trial: Phase II
Latest Information Update: 23 Aug 2017
At a glance
- Drugs Bortezomib (Primary) ; Temsirolimus
- Indications Diffuse large B cell lymphoma; Follicular lymphoma; Mantle-cell lymphoma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 05 Jun 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 10 Dec 2013 Status changed from recruiting to active, no longer recruiting.
- 10 Dec 2013 Results presented at the 55th Annual Meeting and Exposition of the American Society of Hematology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History